181 related articles for article (PubMed ID: 30821276)
21. DNA methylation contributes toward silencing of antioncogenic microRNA-203 in human and canine melanoma cells.
Noguchi S; Mori T; Nakagawa T; Itamoto K; Haraguchi T; Mizuno T
Melanoma Res; 2015 Oct; 25(5):390-8. PubMed ID: 26225581
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3.
Yue J; Lv D; Wang C; Li L; Zhao Q; Chen H; Xu L
Oncogene; 2018 Aug; 37(31):4300-4312. PubMed ID: 29717264
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA H19 promotes glucose metabolism and cell growth in malignant melanoma via miR-106a-5p/E2F3 axis.
Luan W; Zhou Z; Ni X; Xia Y; Wang J; Yan Y; Xu B
J Cancer Res Clin Oncol; 2018 Mar; 144(3):531-542. PubMed ID: 29350287
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
26. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth.
Barsotti AM; Ryskin M; Zhong W; Zhang WG; Giannakou A; Loreth C; Diesl V; Follettie M; Golas J; Lee M; Nichols T; Fan C; Li G; Dann S; Fantin VR; Arndt K; Verhelle D; Rollins RA
Oncotarget; 2015 Feb; 6(5):2928-38. PubMed ID: 25671303
[TBL] [Abstract][Full Text] [Related]
28. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
Lohcharoenkal W; Das Mahapatra K; Pasquali L; Crudden C; Kular L; Akkaya Ulum YZ; Zhang L; Xu Landén N; Girnita L; Jagodic M; Ståhle M; Sonkoly E; Pivarcsi A
J Invest Dermatol; 2018 Apr; 138(4):882-892. PubMed ID: 29104160
[TBL] [Abstract][Full Text] [Related]
29. Gambogic Acid Inhibits Melanoma through Regulation of miR-199a-3p/ZEB1 Signalling.
Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):692-703. PubMed ID: 29959879
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9.
Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L
Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-143 targets Syndecan-1 to repress cell growth in melanoma.
Li R; Zhang L; Jia L; Duan Y; Li Y; Wang J; Bao L; Sha N
PLoS One; 2014; 9(4):e94855. PubMed ID: 24722758
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
[TBL] [Abstract][Full Text] [Related]
34. Targeting signal-transducer-and-activator-of-transcription 3 sensitizes human cutaneous melanoma cells to BRAF inhibitor.
Wang X; Qu H; Dong Y; Wang G; Zhen Y; Zhang L
Cancer Biomark; 2018; 23(1):67-77. PubMed ID: 30010109
[TBL] [Abstract][Full Text] [Related]
35. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
[TBL] [Abstract][Full Text] [Related]
36. EphB4 inhibitor overcome the acquired resistance to cisplatin in melanomas xenograft model.
Yang X; Yang Y; Tang S; Tang H; Yang G; Xu Q; Wu J
J Pharmacol Sci; 2015 Sep; 129(1):65-71. PubMed ID: 26390965
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-21 antisense oligonucleotide improves the sensitivity of A375 human melanoma cell to Cisplatin: An in vitro study.
Zhang HL; Si LB; Zeng A; Long F; Qi Z; Zhao R; Bai M
J Cell Biochem; 2018 Apr; 119(4):3129-3141. PubMed ID: 29058784
[TBL] [Abstract][Full Text] [Related]
38. miR-100 resensitizes resistant epithelial ovarian cancer to cisplatin.
Guo P; Xiong X; Zhang S; Peng D
Oncol Rep; 2016 Dec; 36(6):3552-3558. PubMed ID: 27748936
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.
Luan W; Li L; Shi Y; Bu X; Xia Y; Wang J; Djangmah HS; Liu X; You Y; Xu B
Oncotarget; 2016 Sep; 7(39):63901-63912. PubMed ID: 27564100
[TBL] [Abstract][Full Text] [Related]
40. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.
Deng Y; Zhao F; Hui L; Li X; Zhang D; Lin W; Chen Z; Ning Y
J Ovarian Res; 2017 Jul; 10(1):50. PubMed ID: 28743276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
